MedPath
NMPA Approval

马来酸伊索拉定

国药准字H20020373

July 4, 2024

Drug Information

马来酸伊索拉定

原料药

化学药品

July 4, 2024

Company Information

Applicant Company

江西省南昌市小蓝工业园汇仁西大道758号

Manufacturing Company

江西省南昌市小蓝工业园汇仁西大道758号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

马来酸伊索拉定 - NMPA 批准文号 | MedPath